Stockreport

Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data [MarketWatch]

Ultragenyx Pharmaceutical Inc.  (RARE) 
Last ultragenyx pharmaceutical inc. earnings: 2/13 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ultragenyx.com/investor-relations
PDF Ultragenyx stock up 2.9% after safety and efficacy trial reaffirms Phase 2 data Shares of Ultragenyx Pharmaceutical Inc. RARE, -1.77% rose 2.9% in premarket trade Tue [Read more]